Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Queen RX vs TeleClinic

Queen RX
Graded #192

Higher grade

vs+5.5
TeleClinic
Graded #313

Lower grade

The verdict

Queen RX takes it — 66.3/100 to 60.8/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +33
77
44
Dose & formulationTeleClinic +7
57
64
Clinical oversightTeleClinic +11
69
80
Labs & monitoringQueen RX +1
53
52
FulfillmentTeleClinic +22
75
97
Contract termsQueen RX +41
61
20
Queen RX · left barTeleClinic · right bar

The numbers

MetricQueen RXTeleClinic
WeighScore66.3/10060.8/100
GradeCC
Scorecard rank#192#313
Semaglutide$100/mo (quarterly plan, compounded)$199/mo (compounded)
TirzepatideNot disclosed$299/mo (compounded)
Coverage45 states47 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV
TeleClinic

Graded #313 · C

Strengths

  • Names its pharmacy partner — Rush Pharmacy, a licensed 503A compounder — which many compounded-GLP-1 telehealths won't disclose
  • LegitScript certified with flat, published monthly pricing, free shipping, and no insurance required
  • Broad access: 47 states with US-licensed physicians and transparent cash-pay pricing

Where it loses points

  • Compounded semaglutide and tirzepatide only — no brand-name GLP-1 (Wegovy or Zepbound) option
  • Headline $139/$219 rates are first-quarter intro prices billed quarterly; ongoing month-to-month is $199/$299
  • Not available in California, South Carolina, or New Jersey

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard